ASKA Pharmaceutical : June 9 2023 ASKA Pharmaceutical Terminates Joint Research Agreement regarding the Drug Discovery Targeting Specific Ion Channels with RaQualia Pharma
Press Release ASKA Pharmaceutical Terminates Joint Research Agreement regarding the Drug Discovery Targeting Specific Ion Channels with... | June 9, 2023
Minato Ku Sohta Yamaguchi Raqualia Pharma Termination Of The Joint Research Agreement Co Ltd Head Office
Source: marketscreener.com